About Careers Internship MedBlog Contact us

Breast Cancer Screening With Mammography Curbs Death Risk by Nearly 40%

by Bidita Debnath on June 8, 2015 at 9:33 PM
Font : A-A+

Breast Cancer Screening With Mammography Curbs Death Risk by Nearly 40%

For women aged 50-69, mammography screenings reduce their risk of dying from breast cancer by 40% compared to those who are not screened, claims a study.

"This important analysis will hopefully reassure women around the world that breast screening with mammography saves lives," said Professor Stephen Duffy of Queen Mary University of London. "The evidence proves breast screening is a vital tool in increasing early diagnosis of breast cancer and therefore reducing the number of deaths," Duffy said.


Duffy and experts from 16 countries assessed the positive and negative impact of different breast cancer screening methods, based on a comprehensive analysis of evidence from 11 randomized controlled trials and 40 high-quality observational studies.

"Despite evidence that mammography screening is effective, we still need to carry out further research on alternative screening methods, such as the promising 'digital breast tomosynthesis'; a newly developed form of 3D imaging which could potentially improve the accuracy of mammography in coping with more dense breast tissue," Duffy added.

The latest findings that looked at breast cancer screening on a global level were coordinated by the International Agency for Research in Cancer (IARC), the World Health Organization's specialized cancer agency, and will contribute to an update of the IARC Handbook on breast cancer screening, last published in 2002.

The study was published in the New England Journal of Medicine.

Source: IANS


Recommended Readings

Latest Cancer News

Combination Therapy may Benefit Leukemia Patients
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
 Myelofibrosis: New Drugs to Revolutionize Treatment
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
 Blood Vessels Can Kill Cancer Cells and Stop Breast Cancer Spread
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
 Weed Killer Agent Orange May Increase the Risk of Blood Cancer Among Veterans
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Two Years: Optimal Duration of Immunotherapy in Advanced Lung Cancer
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Breast Cancer Screening With Mammography Curbs Death Risk by Nearly 40% Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests